» Articles » PMID: 35702395

Can Natural Products Modulate Cytokine Storm in SARS-CoV2 Patients?

Overview
Specialty Biotechnology
Date 2022 Jun 15
PMID 35702395
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, the number of cases and deaths of SARS-CoV2, especially among the chronic disease groups, due to aggressive SARS-CoV2 infection is increasing day by day. Various infections, particularly viral ones, cause a cytokine storm resulting in shortness of breath, bleeding, hypotension, and ultimately multi-organ failure due to over-expression of certain cytokines and necrosis factors. The most prominent clinical feature of SARS-CoV2 is the presence of elevated proinflammatory cytokines in the serum of patients with SARS-CoV2. Severe cases exhibit higher levels of cytokines, leading to a "cytokine storm" that further increases disease severity and causes acute respiratory distress syndrome, multiple organ failure, and death. Therefore, targeted cytokine production could be a potential therapeutic option for patients severely infected with SARS-CoV2. Given the current scenario, great scientific progress has been made in understanding the disease and its forms of treatment. Because of natural ingredients properties, they have the potential to be used as potential agents with the ability to modulate immune responses. Moreover, they can be used safely because they have no toxic effects, are biodegradable and biocompatible. However, these natural substances can continue to be used in the development of new therapies and vaccines. Finally, the aim and approach of this review article is to highlight current research on the possible use of natural products with promising potential as immune response activators. Moreover, consider the expected use of natural products when developing potential therapies and vaccines.

Citing Articles

Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study.

Al Balawi A, Eldiasty J, Mosallam S, El-Alosey A, Elmetwalli A Bioresour Bioprocess. 2024; 11(1):108.

PMID: 39604740 PMC: 11602940. DOI: 10.1186/s40643-024-00822-z.


An overview on medicinal plants used for combating coronavirus: Current potentials and challenges.

Abou Baker D, Hassan E, El Gengaihi S J Agric Food Res. 2023; 13:100632.

PMID: 37251276 PMC: 10198795. DOI: 10.1016/j.jafr.2023.100632.


Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.

Nazerian Y, Ghasemi M, Yassaghi Y, Nazerian A, Hashemi S Int Immunopharmacol. 2022; 113(Pt B):109428.

PMID: 36379152 PMC: 9637536. DOI: 10.1016/j.intimp.2022.109428.

References
1.
Monteleone G, Sarzi-Puttini P, Ardizzone S . Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020; 2(5):e255-e256. PMC: 7193140. DOI: 10.1016/S2665-9913(20)30092-8. View

2.
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

3.
Berretta A, Duarte Silveira M, Condor Capcha J, de Jong D . Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother. 2020; 131:110622. PMC: 7430291. DOI: 10.1016/j.biopha.2020.110622. View

4.
Pei X, Zhang X, Chen H . Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling. Biochem Biophys Res Commun. 2019; 516(1):270-277. DOI: 10.1016/j.bbrc.2019.06.006. View

5.
Yang Y, Ding Z, Wang Y, Zhong R, Feng Y, Xia T . Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury. J Cell Mol Med. 2020; 24(9):5039-5056. PMC: 7205831. DOI: 10.1111/jcmm.15126. View